Advanced Biological Laboratories (ABL) S.A. acquired 96.7% stake in Fauvet-Girel (ENXTPA:FAUV) from STE Parisienne De Construction Et De Location and seven natural persons for €3.9 million on October 15, 2021. Advanced Biological Laboratories acquired 0.24 million shares of Fauvet-Girel at €15.9 per share. STE Parisienne De Construction Et De Location sold 91.47% stake and seven natural persons sold 5.22% stake. Advanced Biological Laboratories (ABL) S.A. completed the acquisition of 96.7% stake in Fauvet-Girel (ENXTPA:FAUV) from STE Parisienne De Construction Et De Location and seven natural persons on October 15, 2021.